Blog Posts

U.C. Berkeley Researcher Proposes 340B Be Limited to the Indigent or that Providers Pass on their Discounts to Insurance Industry

Dr. James Robinson, a health economist at University of California at Berkley, criticized hospitals’ “buy and bill” drug acquisition process.
A University of California at Berkeley academic is proposing a series of major reforms to the 340B discount drug program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Urges Federal Court to Reject Health Systems’ Challenge to 340B Child Site Registration Policy Reversal

HRSA asked a federal district court to dismiss 44 health systems' challenge to its 340B child site registration policy reversal.
The Health Resources and Services Administration (HRSA) has asked a federal court to dismiss a lawsuit from forty-four health systems [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Key Takeaways from the SUSTAIN 340B Act and Things to Consider When Weighing In (Part 2)

Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.
In February, the U.S. Senate bipartisan “Group of Six” released an eagerly anticipated discussion draft bill and a bill summary/request [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Long-Awaited Federal Bill to Protect Contract Pharmacy Arrangements Introduced

Doris Matsui
Rep. Doris Matsui (D-Calif.) introduced federal legislation to prohibit drugmaker 340B contract pharmacy restrictions.
Long-awaited federal legislation to bar drugmaker restrictions on 340B contract pharmacy arrangements was introduced today. The Mar 12 bill sponsored [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

In Key Decision That Could Have National Implications, Federal Appellate Court Upholds Arkansas 340B Contract Pharmacy Protection Law

Circuit Judge Michael Melloy of the U.S. 8th Circuit Court of Appeals wrote the opinion that upheld Arkansas' state 340B contract pharmacy law.
A federal appeals court today upheld an Arkansas law that prohibits drug manufacturer 340B contract pharmacy restrictions in the state. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genentech Is Thirty-first Company to Implement Contract Pharmacy Restrictions

Genentech building
Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.
Drugmaker Genentech has given some 340B hospitals advance notice of its plan to implement contract pharmacy restrictions. The biotech giant, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Biden Budget Request Keeps OPA Funding Flat

President Joe Biden's fiscal year 2025 budget would increase HRSA funding but not the budget of OPA, the office that oversees the 340B program.
Despite the looming finalization of a major policy change, this week’s fiscal year 2025 budget request would freeze the budget [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Conservative Media Campaign Continues, Hospital Group Demands Removal of Ads Linking 340B to Illegal Immigration

A 340B hospital trade group demanded local stations remove a dark money ad that links the 340B program to immigration growth.
A national hospital advocacy group “insists” multiple television stations remove a dark money group’s political ads alleging federal funding for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report